Welch Allyn
Welch Allyn, Inc., founded in 1915 and based in Skaneateles Falls, New York, is an American manufacturer specializing in medical diagnostic devices and patient monitoring systems. The company employs over 2,750 individuals and operates manufacturing, sales, and distribution facilities globally. Welch Allyn produces a range of products focused on physical assessment, vital signs monitoring, diagnostic cardiopulmonary care, blood pressure measurement, and thermometry. By offering these medical diagnostic tools, the company aims to enhance early diagnosis and facilitate appropriate treatment for patients.
EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in 2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts.
Hubble Telemedical focuses on the early detection of systemic and debilitating diseases that can be identified through retinal examination. Their Telemedical Retinal Image Analysis and Diagnosis (TRIAD) technology offers real-time diagnosis of diabetic retinopathy and other retinal conditions, utilizing commonly available retina cameras. This innovative approach addresses the issue of many at-risk individuals not receiving necessary annual retinal exams due to accessibility and convenience challenges. By partnering with healthcare providers, insurance companies, and employers, Hubble Telemedical aims to make retinal screening more accessible, ultimately improving health outcomes and reducing healthcare costs. Their services are fully compliant with HIPAA regulations, ensuring security and ease of use. Clinical studies support the effectiveness of their technology in increasing annual screening compliance, thereby enhancing patient care and facilitating timely treatment for various diseases.
Cardiac Insight Inc. develops body-worn sensing and computing technologies for diagnostic testing in cardiology, respiratory, and other complex disease states. The company offers CardeaScreen, an electrocardiographic device that measures and records the electrical activity of the heart, and helps physicians conducting pre-participation exams to identify athletes with abnormal heart conditions. Its products are used by pediatricians, primary care physicians, cardiologists, sports team physicians, professional trainers, and community screening organizations. The company was incorporated in 2008 and is based in Bellevue, Washington.
Cyrano Sciences, is focused on providing chemical and biological sensors and software solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.